Home - Products - Angiogenesis - Bcl-2 - (22E)-Ergosta-4,6,8(14),22-tetraen-3-one

(22E)-Ergosta-4,6,8(14),22-tetraen-3-one

CAS No. 19254-69-4

(22E)-Ergosta-4,6,8(14),22-tetraen-3-one( ——— )

Catalog No. M39405 CAS No. 19254-69-4

Ergosta-4,6,8(14),22-tetraen-3-one (compound 2) is a ergosteroid is isolated from the fruiting bodies of ganoderma applanatum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (22E)-Ergosta-4,6,8(14),22-tetraen-3-one
  • Note
    Research use only, not for human use.
  • Brief Description
    Ergosta-4,6,8(14),22-tetraen-3-one (compound 2) is a ergosteroid is isolated from the fruiting bodies of ganoderma applanatum.
  • Description
    Ergosta-4,6,8(14),22-tetraen-3-one has cytotoxic activity against human gastric cancer cell, it can induce G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells, these results would be useful for the further utilization of many medicinal fungi in cancer treatment.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    Bcl-2; p53; Caspase
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    19254-69-4
  • Formula Weight
    392.62
  • Molecular Formula
    C28H40O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 20 mg/mL (50.94 mM; ultraphonic; )
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gan KH, et al. Steroidal constituents of ganoderma applanatum and ganodermaneo-japonicum. J Nat Prod. 1998 Nov;61(11):1421-2.?
molnova catalog
related products
  • BCL6 inhibitor 14

    BCL6 inhibitor 14 is a potent BCL-6 inhibitor with FRET IC50 of 63 nM.

  • BCL6-IN-8

    BCL6-IN-8 (BCL6-i) is a potent, irreversible and cell-active BCL6 inhibitor with inact/KI value of 1.9 × 104 M-1 s-1, targets Cys53 located at the protein-protein interaction interface.

  • S55746 hydrochloride

    S55746 (BCL201, Servier-1) is a novel potent, selective, orally bioavailable inhibitor of BCL-2 with Ki of 1.3 nM.